🟢 Lantern Pharma is trading 12.85% up today in pre-market with XBI up 2.27%

Lantern Pharma is trading 12.85% up at $2.81 amid biotech sentiment, with XBI up 2.27% pre-market amid positive cancer-trial news.

• No verified company-specific announcement emerged overnight.
• The August 14 earnings release highlighted improved operating efficiency and clinical progress but is not a fresh catalyst.
• Trading activity appears elevated in extended hours following the August 19 after-hours jump.